Defending against oxidative stress caused by UV rays and pollution
The peptide has also been investigated for its effects on metalloproteinase balance, simultaneously upregulating tissue-repair MMPs while modulating TIMP expression
Recent investigations into the gut microbiome reveal a concerning prevalence of dysbiosis in ME/CFS patients, characterized by reduced microbial diversity and an imbalance between beneficial and harmful bacteria [1, 10,11,12,13,14]
This systemic inflammation is a major driver of the profound fatigue, joint pain, and vascular instability seen in dysautonomia and ME/CFS
What BPC-157 Research Is Missing Honest assessment - here's what the published literature lacks: No Human Clinical Trials (Yet) As of early 2026, BPC-157 has zero completed human clinical trials in peer-reviewed journals